Skip to main content

Healthy Male Volunteer

3
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
AZD1981Phase 11 trial
Active Trials
NCT00859352Completed28Est. Apr 2009
Chong Kun Dang Pharmaceutical
1 program
1
CKD-501 0.5 mg tablet, Glimepiride 4 mg tabletPhase 11 trial
Active Trials
NCT01133431Completed24Est. Aug 2010
Dong-A ST
Dong-A STKorea - Seoul
1 program
1
Exforge®Phase 11 trial
Active Trials
NCT01776047Completed51Est. Sep 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Dong-A STExforge®
Chong Kun Dang PharmaceuticalCKD-501 0.5 mg tablet, Glimepiride 4 mg tablet
AstraZenecaAZD1981

Clinical Trials (3)

Total enrollment: 103 patients across 3 trials

NCT01776047Dong-A STExforge®

A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

Start: Jul 2012Est. completion: Sep 201251 patients
Phase 1Completed
NCT01133431Chong Kun Dang PharmaceuticalCKD-501 0.5 mg tablet, Glimepiride 4 mg tablet

The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea

Start: May 2010Est. completion: Aug 201024 patients
Phase 1Completed
NCT00859352AstraZenecaAZD1981

AZD1981 Midazolam CYP4503A Induction Study

Start: Mar 2009Est. completion: Apr 200928 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.